"There are many ways to define excellence. For The Christ Hospital in Cincinnati, OH, it's all about our patients. And making healthcare what they want it to be. Accessible. Personal. Affordable."

During the past decade, Christ Hospital Cancer Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 10 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Christ Hospital Cancer Center" #1 sponsor was "NSABP Foundation Inc" with 5 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Eastern Cooperative Oncology Group" with 4 trials sponsored, "Gritstone bio, Inc." with 2 trials sponsored and "Peregrine Pharmaceuticals" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Christ Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Christ Hospital Cancer Center" are "Breast Cancer" (6 trials), "Melanoma" (4 trials), "Lymphoma" (3 trials), "Colorectal Neoplasms" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Christ Hospital Cancer Center" in a lesser frequency.

Most popular intervention types in "Christ Hospital Cancer Center" are "Drug" (26 trials), "Biological" (7 trials), "Other" (4 trials), "Radiation" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ipilimumab" (4 trials), "Atezolizumab" (2 trials), "GRT-C901" (2 trials), "GRT-R902" (2 trials) and "Letrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Christ Hospital Cancer Center" are 26 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Christ Hospital Cancer Center". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Christ Hospital Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Christ Hospital Cancer Center, 5 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".